Emily
Editor, Senior Moderator
https://pubmed.ncbi.nlm.nih.gov/34661250/
Concistrè A, Alessandri F, Rosato E, Pugliese F, Muscaritoli M, Letizia C. A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection. Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5922-5927. doi: 10.26355/eurrev_202110_26868. PMID: 34661250.
Abstract
Systemic capillary leak syndrome (SCLS) is a very rare and lethal disease characterized by hemoconcentration and hypoalbuminemia caused by reversible plasma extravasation. The underlying cause for SCLS remains largely unknown and acute treatment has remained mainly supportive. Prophylaxis with intravenous immunoglobulin (IVIG) has been shown to successfully prevent further episodes in affected patients. We reported a case of SCLS in a patient who presented to our hospital with COVID-19 and developed profound shock.
Concistrè A, Alessandri F, Rosato E, Pugliese F, Muscaritoli M, Letizia C. A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection. Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5922-5927. doi: 10.26355/eurrev_202110_26868. PMID: 34661250.
Abstract
Systemic capillary leak syndrome (SCLS) is a very rare and lethal disease characterized by hemoconcentration and hypoalbuminemia caused by reversible plasma extravasation. The underlying cause for SCLS remains largely unknown and acute treatment has remained mainly supportive. Prophylaxis with intravenous immunoglobulin (IVIG) has been shown to successfully prevent further episodes in affected patients. We reported a case of SCLS in a patient who presented to our hospital with COVID-19 and developed profound shock.